• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清炎症标志物在克罗恩病活动度的诊断与评估中的应用

Serum inflammatory markers in the diagnosis and assessment of Crohn's disease activity.

作者信息

Słowińska-Solnica Krystyna, Pawlica-Gosiewska Dorota, Gawlik Katarzyna, Owczarek Danuta, Cibor Dorota, Pocztar Halina, Mach Tomasz, Solnica Bogdan

机构信息

Department of Clinical Biochemistry, Jagiellonian University Medical College, Krakow, Poland.

Department of Gastroenterology and Hepatology, Jagiellonian University Medical College, Krakow, Poland.

出版信息

Arch Med Sci. 2021 Jan 5;17(1):252-257. doi: 10.5114/aoms/130842. eCollection 2021.

DOI:10.5114/aoms/130842
PMID:33488879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7811324/
Abstract

INTRODUCTION

The aim of our study was to evaluate the diagnostic characteristics of selected inflammatory markers and the results of multiplication of their concentrations in the diagnosis and assessment of Crohn's disease (CD) activity.

METHODS

We studied 49 patients with CD and 31 healthy controls. The CD patients were assigned to subgroups with active and inactive disease based on the Crohn's Disease Activity Index score. Serum interleukins and C-reactive protein (CRP) were measured using immunoassays.

RESULTS

Serum CRP and interleukins: IL-6, IL-17A, IL-23 were significantly higher in the CD group than in controls, with the best diagnostic performance for IL-23. Only serum IL-6 and CRP were significantly higher in active than in inactive disease, with the better performance of CRP. Multiplication results did not perform better than individual multipliers.

CONCLUSIONS

Serum CRP may be useful in the assessment of CD activity and there is a need for introduction of IL-23 for the CD diagnosis.

摘要

引言

我们研究的目的是评估所选炎症标志物的诊断特征及其浓度乘积结果在克罗恩病(CD)活动诊断和评估中的作用。

方法

我们研究了49例CD患者和31名健康对照者。根据克罗恩病活动指数评分,将CD患者分为疾病活动组和非活动组。采用免疫分析法检测血清白细胞介素和C反应蛋白(CRP)。

结果

CD组血清CRP以及白细胞介素IL-6、IL-17A、IL-23显著高于对照组,其中IL-23的诊断性能最佳。仅血清IL-6和CRP在活动期疾病中显著高于非活动期疾病,CRP的性能更佳。浓度乘积结果并不比单个标志物更好。

结论

血清CRP可能有助于评估CD活动,并且有必要引入IL-23用于CD诊断。

相似文献

1
Serum inflammatory markers in the diagnosis and assessment of Crohn's disease activity.血清炎症标志物在克罗恩病活动度的诊断与评估中的应用
Arch Med Sci. 2021 Jan 5;17(1):252-257. doi: 10.5114/aoms/130842. eCollection 2021.
2
Changes in serum levels of lipopolysaccharides and CD26 in patients with Crohn's disease.克罗恩病患者血清脂多糖和CD26水平的变化。
Intest Res. 2017 Jul;15(3):352-357. doi: 10.5217/ir.2017.15.3.352. Epub 2017 Jun 12.
3
Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.炎症性肠病中肠道炎症评估的非侵入性标志物:粪便乳铁蛋白、钙卫蛋白、PMN弹性蛋白酶、CRP及临床指标的表现
Am J Gastroenterol. 2008 Jan;103(1):162-9. doi: 10.1111/j.1572-0241.2007.01556.x. Epub 2007 Oct 4.
4
Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn's Disease Severity.评估同种异体移植炎症因子-1(AIF-1)作为克罗恩病严重程度的生物标志物
Biomedicines. 2022 Mar 21;10(3):727. doi: 10.3390/biomedicines10030727.
5
Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.克罗恩病和溃疡性结肠炎患者体内的炎症介质与急性期蛋白
Hepatogastroenterology. 1997 Jan-Feb;44(13):90-107.
6
Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease.克罗恩病患者疾病活动与血清及粪便生物标志物之间的关系。
Clin Gastroenterol Hepatol. 2008 Nov;6(11):1218-24. doi: 10.1016/j.cgh.2008.06.010. Epub 2008 Sep 17.
7
Serum calprotectin as a biomarker for Crohn's disease.血清钙卫蛋白作为克罗恩病的生物标志物。
J Crohns Colitis. 2013 Dec;7(12):e678-83. doi: 10.1016/j.crohns.2013.06.008. Epub 2013 Jul 9.
8
Interrelations between interleukin-6, interleukin-1 beta, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease.炎症性肠病患者白细胞介素-6、白细胞介素-1β、血浆C反应蛋白值与体外C反应蛋白生成之间的相互关系。
Gut. 1994 Jan;35(1):77-83. doi: 10.1136/gut.35.1.77.
9
Simple Enterographic Activity Score for Crohn's Disease: comparison with endoscopic, biochemical, and clinical findings.克罗恩病的简易肠道造影活动评分:与内镜、生化及临床检查结果的比较
Pol Arch Med Wewn. 2013;123(7-8):378-85. doi: 10.20452/pamw.1825. Epub 2013 Jun 14.
10
Serum interleukin 17 levels in patients with Crohn's disease: real life data.克罗恩病患者的血清白细胞介素17水平:真实数据
Dis Markers. 2014;2014:690853. doi: 10.1155/2014/690853. Epub 2014 Jul 16.

引用本文的文献

1
Pro-inflammatory and anti-inflammatory cytokines as candidate markers in the diagnosis and assessment of Crohn's disease activity.促炎和抗炎细胞因子作为克罗恩病活动诊断和评估中的候选标志物。
Arch Med Sci. 2022 Aug 11;21(3):808-816. doi: 10.5114/aoms/152645. eCollection 2025.
2
Identification of Potential Functional Modules and Diagnostic Genes for Crohn's Disease Based on Weighted Gene Co-expression Network Analysis and LASSO Algorithm.基于加权基因共表达网络分析和LASSO算法的克罗恩病潜在功能模块和诊断基因的鉴定
Turk J Gastroenterol. 2025 Jan 6;36(4):209-218. doi: 10.5152/tjg.2025.23605.
3
Development and validation of a predictive model for endoscopic improvement of Crohn's disease.克罗恩病内镜改善预测模型的开发与验证
World J Gastrointest Endosc. 2025 Feb 16;17(2):100665. doi: 10.4253/wjge.v17.i2.100665.
4
Assessment of the Utility of Selected Inflammatory Markers in Correlation with Magnetic Resonance Enterography (MRE) Findings in the Diagnosis of Crohn's Disease.评估所选炎症标志物与磁共振小肠造影(MRE)结果相关联在克罗恩病诊断中的效用。
Biomolecules. 2025 Jan 13;15(1):116. doi: 10.3390/biom15010116.
5
New score models for assessing disease activity in Crohn's disease based on bowel ultrasound and biomarkers: Ideal surrogates for endoscopy or imaging.基于肠道超声和生物标志物的克罗恩病疾病活动评估新评分模型:内镜或影像学的理想替代指标。
Clin Transl Sci. 2023 Sep;16(9):1639-1652. doi: 10.1111/cts.13575. Epub 2023 Jul 21.
6
Soluble Protein Hydrolysate Ameliorates Gastrointestinal Inflammation and Injury in 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis in Mice.可溶性蛋白水解物可改善 2,4,6-三硝基苯磺酸诱导的小鼠结肠炎的胃肠道炎症和损伤。
Biomolecules. 2022 Sep 13;12(9):1287. doi: 10.3390/biom12091287.
7
MRI-Based Radiomic Signature Identifying Secondary Loss of Response to Infliximab in Crohn's Disease.基于MRI的放射组学特征识别克罗恩病中对英夫利昔单抗继发的反应丧失
Front Nutr. 2022 Jan 3;8:773040. doi: 10.3389/fnut.2021.773040. eCollection 2021.
8
Plasma elafin, cathelicidin, and α-defensins are increased in paediatric inflammatory Crohn's disease and reflect disease location.血浆弹性蛋白、杀菌肽和α-防御素在儿童炎症性克罗恩病中升高,并反映疾病部位。
Arch Med Sci. 2021 Jun 11;17(4):1114-1117. doi: 10.5114/aoms/138349. eCollection 2021.
9
Anti-Inflammatory Activity of Oat Beta-Glucans in a Crohn's Disease Model: Time- and Molar Mass-Dependent Effects.燕麦β-葡聚糖在克罗恩病模型中的抗炎活性:时间和分子量依赖性效应。
Int J Mol Sci. 2021 Apr 25;22(9):4485. doi: 10.3390/ijms22094485.

本文引用的文献

1
Association of serum interleukin-6 and soluble interleukin-2-receptor levels with disease activity status in patients with inflammatory bowel disease: A prospective observational study.血清白细胞介素-6 和可溶性白细胞介素-2 受体水平与炎症性肠病患者疾病活动状态的相关性:一项前瞻性观察研究。
PLoS One. 2020 May 29;15(5):e0233811. doi: 10.1371/journal.pone.0233811. eCollection 2020.
2
On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases.治疗过程中血清白细胞介素-6的降低作为炎症性肠病患者生物治疗临床反应的预测指标
J Clin Med. 2020 Mar 15;9(3):800. doi: 10.3390/jcm9030800.
3
Combined Use of Common Fecal and Blood Markers for Detection of Endoscopically Active Inflammatory Bowel Disease.联合使用常见粪便和血液标志物检测内镜下活动性炎症性肠病
Clin Transl Gastroenterol. 2020 Mar;11(3):e00138. doi: 10.14309/ctg.0000000000000138.
4
Serum C-reactive protein and albumin are useful biomarkers for tight control management of Crohn's disease in Japan.血清 C 反应蛋白和白蛋白是日本克罗恩病紧密控制管理的有用生物标志物。
Sci Rep. 2020 Jan 16;10(1):511. doi: 10.1038/s41598-020-57508-7.
5
A Combined Set of Four Serum Inflammatory Biomarkers Reliably Predicts Endoscopic Disease Activity in Inflammatory Bowel Disease.一组四种血清炎症生物标志物可可靠预测炎症性肠病的内镜疾病活动度。
Front Med (Lausanne). 2019 Nov 5;6:251. doi: 10.3389/fmed.2019.00251. eCollection 2019.
6
Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies.白细胞介素 (IL)-17 在炎症和免疫性疾病中的关键作用:聚焦争议的证据更新综述。
Autoimmun Rev. 2020 Jan;19(1):102429. doi: 10.1016/j.autrev.2019.102429. Epub 2019 Nov 15.
7
Combined evaluation of biomarkers as predictor of maintained remission in Crohn's disease.联合生物标志物评估预测克罗恩病缓解持续状态。
World J Gastroenterol. 2019 May 21;25(19):2354-2364. doi: 10.3748/wjg.v25.i19.2354.
8
Update on C-reactive protein and fecal calprotectin: are they accurate measures of disease activity in Crohn's disease?C 反应蛋白和粪便钙卫蛋白更新:它们是否能准确衡量克罗恩病的疾病活动度?
Expert Rev Gastroenterol Hepatol. 2019 Apr;13(4):319-330. doi: 10.1080/17474124.2019.1563481. Epub 2019 Jan 3.
9
IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting.IL-12、IL-23 和 IL-17 在炎症性肠病中的作用:免疫生物学和治疗靶点。
Nat Rev Gastroenterol Hepatol. 2019 Mar;16(3):185-196. doi: 10.1038/s41575-018-0084-8.
10
Correlation of Paraoxonase-1 with the Severity of Crohn's Disease.对氧磷酶 1 与克罗恩病严重程度的相关性。
Molecules. 2018 Oct 11;23(10):2603. doi: 10.3390/molecules23102603.